Relationship between use of antidepressants and risk of fractures: a meta-analysis

Use of Antidepressant Medications and Risk of Fracture in Older Women

(2011) Susan J. Diem et al.   CALCIFIED TISSUE INTERNATIONAL

Binge drinking: all too prevalent and hazardous

(2011) K. Flegel et al.   CANADIAN MEDICAL ASSOCIATION JOURNAL

Antidepressants and Fracture Risk in Older Adults: A Comparative Safety Analysis

(2011) J J Gagne et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

The adverse skeletal effects of selective serotonin reuptake inhibitors

(2011) E.M. Tsapakis et al.   EUROPEAN PSYCHIATRY

Depression, Antidepressants, and Bone Mineral Density in a Population-Based Cohort

(2011) B. Mezuk et al.   JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES

Depressive Disorder and Incident Diabetes Mellitus: The Effect of Characteristics of Depression

(2010) Antonio Campayo et al.   AMERICAN JOURNAL OF PSYCHIATRY

Psychotropic drugs and the risk of fractures in old age: a prospective population-based study

(2010) Janne Nurminen et al.   BMC PUBLIC HEALTH

Use of antidepressant drugs and risk of osteoporotic and non-osteoporotic fractures

(2010) Bertha Maria Verdel et al.   BONE

The two faces of serotonin in bone biology

(2010) Patricia Ducy et al.   JOURNAL OF CELL BIOLOGY

Meta-analysis of the Impact of 9 Medication Classes on Falls in Elderly Persons

(2009) John C. Woolcott   ARCHIVES OF INTERNAL MEDICINE

The emerging role of serotonin (5-hydroxytryptamine) in the skeleton and its mediation of the skeletal effects of low-density lipoprotein receptor-related protein 5 (LRP5)

(2009) Stuart J. Warden et al.   BONE

Effects of selective serotonin reuptake inhibitors on bone health in adults: Time for recommendations about screening, prevention and management?

(2009) Elizabeth M. Haney et al.   BONE

SSRIs, bone mineral density, and risk of fractures — a review

(2009) Sofie Schwan et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Selective serotonin reuptake inhibitor use and bone mineral density in women with a history of depression

(2009) Lana J. Williams et al.   INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration

(2009) Alessandro Liberati et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

Selective Serotonin Reuptake Inhibiting Antidepressants Are Associated With an Increased Risk of Nonvertebral Fractures

(2009) Gijsbertus Ziere et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Fracture Risk From Psychotropic Medications

(2009) James M. Bolton et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Use of anti-depressants and the risk of fracture of the hip or femur

(2009) M. W. M. van den Brand et al.   OSTEOPOROSIS INTERNATIONAL

Bone mineral density and disorders of mineral metabolism in chronic liver disease

(2009) Joe George et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Risk of Fractures with Selective Serotonin-Reuptake Inhibitors or Tricyclic Antidepressants

(2008) Regina Ginzburg et al.   ANNALS OF PHARMACOTHERAPY

Depressive Symptoms, Bone Loss, and Fractures in Postmenopausal Women

(2008) Leslie Spangler et al.   JOURNAL OF GENERAL INTERNAL MEDICINE

Mapping the prescriptiome to fractures in men—a national analysis of prescription history and fracture risk

(2008) B. Abrahamsen et al.   OSTEOPOROSIS INTERNATIONAL

Population-based study of the effectiveness of bone-specific drugs in reducing the risk of osteoporotic fracture

(2008) Sylvie Perreault et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY